Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene... by Egle Stukaite-Ruibiene, Rimvydas Norvilas, Rimvydas Norvilas, Vaidas Dirse, Sigita Stankeviciene, Goda Elizabeta Vaitkeviciene, Goda Elizabeta Vaitkeviciene

Get full text

Implementation and Evaluation of Preimplantation Genetic Testing at Vilnius University Hospital Santaros Klinikos by Eglė Stukaitė-Ruibienė, Živilė Gudlevičienė, Andrė Amšiejienė, Evelina Dagytė, Rimantas Gricius, Kristina Grigalionienė, Algirdas Utkus, Diana Ramašauskaitė

Get full text

Supplement by Zanna Kovalova, Anda Kivite-Urtane, Jelena Rascon, Audronė Mulevičienė, Goda Elizabeta Vaitkevičienė, Kajus Merkevičius, Eglė Stukaitė-Ruibienė, Sonata Šaulytė Trakymienė

Get full text

Development of a questionnaire to evaluate female fertility care in pediatric oncology, a TREL initiative by M. E. Madeleine van der Perk, Eglė Stukaitė-Ruibienė, Žana Bumbulienė, Goda Elizabeta Vaitkevičienė, Annelies M. E. Bos, Marry M. van den Heuvel-Eibrink, Jelena Rascon

Get full text

Evaluation of oncofertility care in childhood cancer patients: the EU-Horizon 2020 twinning project TREL initiative by Egle Stukaite-Ruibiene, M. E. Madeleine van der Perk, Goda Elizabeta Vaitkeviciene, Goda Elizabeta Vaitkeviciene, Annelies M. E. Bos, Zana Bumbuliene, Zana Bumbuliene, Marry M. van den Heuvel-Eibrink, Jelena Rascon, Jelena Rascon

Get full text